VSA enters LOI to acquire HopeAI, accelerating expansion into AI in life science
This strategic move is expected to significantly advance VSA's expansion into the AI biopharmaceutical sector and strengthen its presence in intelligent healthcare and technology innovation.
VSA Expansion Into The AI Biopharmaceutical Sector | 18/06/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy